Detecting bladder cancer early using a new urine test.
A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and its Implications in Tumor Biology
This study is working on a new urine test to help find bladder cancer early, especially for people who are at higher risk, so they can get treated sooner and improve their chances of recovery.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cedars-Sinai Medical Center NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11042277 on NIH RePORTER |
What this research studies
This research focuses on developing a new urine test that can detect bladder cancer at an early stage, which is crucial for improving survival rates. The approach involves identifying a specific set of biomarkers associated with bladder cancer and creating a multiplex immunoassay to analyze these biomarkers in urine samples. By testing individuals who are at high risk for bladder cancer, the researchers aim to provide a reliable screening method that can lead to earlier diagnosis and better treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk for bladder cancer, particularly those exposed to certain carcinogens.
Not a fit: Patients who do not have risk factors for bladder cancer or those already diagnosed with advanced stages of the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve early detection of bladder cancer, leading to higher survival rates for patients.
How similar studies have performed: Previous research has shown promising results with similar biomarker-based approaches for cancer detection, indicating potential for success in this area.
Where this research is happening
Los Angeles, United States
- Cedars-Sinai Medical Center — Los Angeles, United States (Active)
Researchers
- Principal investigator: Rosser, Charles J — Cedars-Sinai Medical Center
- Study coordinator: Rosser, Charles J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.